By – Jawahar Mishra
…………………………………………………………………….
Highlights – Amid America’s 100% tariff, China opens doors for Indian pharmaceutical companies, paving the way for billions of dollars in exports.
China has given a major gift to Indian pharmaceutical companies. The 30% import duty on medicines has been removed, opening new doors for exports.
…………………………………………………………………….
China has brought significant good news to the Indian pharmaceutical industry. China has reduced the 30% import duty on Indian pharmaceutical products to zero. This means that Indian companies will now be able to sell medicines to China without any customs duty. This move comes at a time when the US has virtually shut down the market by imposing a 100% tariff on Indian medicines. China’s decision brings relief and new opportunities for the Indian pharmaceutical sector.
Why China’s move is important
India is called the “pharmacy of the world” because generic medicines and vaccines manufactured here are supplied worldwide at affordable prices. Until now, the Chinese market was difficult for Indian companies because the 30% duty increased the cost of medicines. Now, with zero duty, Indian companies will have the opportunity to compete directly in a huge market like China. This will not only increase exports but also strengthen India’s hold in the global healthcare supply chain.
A New Opportunity Worth Billions of Dollars
Experts believe this decision will help improve the India-China trade balance. Until now, trade has been heavily skewed in China’s favor, but India could benefit significantly from pharmaceutical exports. According to industry experts, Indian pharmaceutical exports could grow to billions of dollars in the coming years. This will also create new employment opportunities in the country and lead to a significant surge in corporate income.
India’s Role in Global Healthcare Strengthens
The pharmaceutical industry believes this move will give India a stronger position in the global healthcare supply chain. After the shock of the US market, this relief from China will allow Indian companies to balance and expand rapidly into new markets. According to experts, this decision could prove to be a game changer not only for India’s economy but also for the supply of affordable and reliable medicines to the entire world.
